Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Feb 23;48(12):1373–1383. doi: 10.1007/s00535-013-0763-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2013

Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

PMC Copyright notice

Fig. 1 — Individual patients’ timecourse of anti-HBs antibody titer after vaccine administration. The timecourse of the anti-HBs antibody titer after the first vaccine administration is shown. The arrowhead indicates a vaccine administration point, and the square head indicates an HBIg administration point. a Patients who received orthotopic liver transplantation (OLT) due to hepatitis B-related acute liver failure (ALF-OLT). All patients had a good response to vaccination. b Patients who received OLT due to liver cirrhosis with a good response to vaccination (LC-OLT good). c LC-OLT patients with a poor response to vaccination (LC-OLT poor)

Fig. 1 — Individual patients’ timecourse of anti-HBs antibody titer after vaccine administration. The timecourse of the anti-HBs antibody titer after the first vaccine administration is shown. The arrowhead indicates a vaccine administration point, and the square head indicates an HBIg administration point. a Patients who received orthotopic liver transplantation (OLT) due to hepatitis B-related acute liver failure (ALF-OLT). All patients had a good response to vaccination. b Patients who received OLT due to liver cirrhosis with a good response to vaccination (LC-OLT good). c LC-OLT patients with a poor response to vaccination (LC-OLT poor)